Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial
- 24 August 2006
- journal article
- clinical trial
- Published by Springer Nature in Leukemia
- Vol. 20 (10) , 1840-1847
- https://doi.org/10.1038/sj.leu.2404346
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001Blood, 2006
- Treatment Strategies in Follicular Lymphomas: Current Status and Future PerspectivesJournal of Clinical Oncology, 2005
- The clinical course of follicular lymphomaBest Practice & Research Clinical Haematology, 2005
- CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphomaBlood, 2005
- 131I-Tositumomab Therapy as Initial Treatment for Follicular LymphomaNew England Journal of Medicine, 2005
- Follicular Lymphoma International Prognostic IndexBlood, 2004
- Fludarabine Plus Mitoxantrone With and Without Rituximab Versus CHOP With and Without Rituximab As Front-Line Treatment for Patients With Follicular LymphomaJournal of Clinical Oncology, 2004
- Future directions in radioimmunotherapy for B-cell lymphomaSeminars in Oncology, 2003
- Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma.Journal of Clinical Oncology, 1994
- Prolonged Disease-Free Survival after Autologous Bone Marrow Transplantation in Patients with Non-Hodgkin's Lymphoma with a Poor PrognosisNew England Journal of Medicine, 1987